VBI Vaccines
VBIV64
$0.01arrow_drop_up1.40%$0.00
High Value
Penny Stock
VBIV64
$0.01
arrow_drop_up1.40%Performance History
| Key Stats | |
|---|---|
| Open | $0.01 |
| Prev. Close | $0.01 |
| EPS | -3.54 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $1.87M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.01 | 0.02 |
| 52 Week Range | 0.01 | 1.35 |
| Ratios | |
|---|---|
| Revenue | - |
| EPS | -3.54 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About VBI Vaccines (VBIV)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jeffery R. Baxter FCMA
- Headquarters
- Cambridge
- Employees
- 190
- Exchange
- NASDAQ
Keep an eye on VBI Vaccines
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is VBI Vaccines 's (VBIV) price per share?
The current price per share for VBI Vaccines (VBIV) is $0.02. The stock has seen a price change of $0 recently, indicating a 1.41% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for VBI Vaccines (VBIV)?
For VBI Vaccines (VBIV), the 52-week high is $1.35, which is 7.4K% from the current price. The 52-week low is $0.01, the current price is 36.36% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is VBI Vaccines (VBIV) a growth stock?
VBI Vaccines (VBIV) has shown an average price growth of -2.21% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying VBI Vaccines as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is VBI Vaccines (VBIV) stock price performance year to date (YTD)?
As of the latest data, VBI Vaccines (VBIV) has a year-to-date price change of . Over the past six months, the figure is -97.69%. Looking at a longer horizon, the five-year price change stands at -99.97%.
help
Is VBI Vaccines (VBIV) a profitable company?
VBI Vaccines (VBIV) has a net income of -$92.84M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -968.04% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$55.31M. Furthermore, the EBITDA is -$45.58M.
help
What is the market capitalization of VBI Vaccines (VBIV)?
VBI Vaccines (VBIV) has a market capitalization of $1.87M. The average daily trading volume is 226.3K, indicating the stock's liquidity and investor engagement.